IGM BIOSCIENCES DL-01
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M antibodies for the treatment of cancer and autoimmune and inflammatory diseases. The company was formerly known as Palingen, Inc. and changed its name to IGM Biosciences, Inc. in 2010. IGM Biosciences, Inc. was incorporated in 1993 and is headquartered in Mountain View, California. As of August 14, 2025, IGM Biosciences, In… Read more
IGM BIOSCIENCES DL-01 (1K0) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, IGM BIOSCIENCES DL-01 (1K0) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
IGM BIOSCIENCES DL-01 - Net Assets Trend (None–None)
This chart illustrates how IGM BIOSCIENCES DL-01's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for IGM BIOSCIENCES DL-01 (None–None)
The table below shows the annual net assets of IGM BIOSCIENCES DL-01 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to IGM BIOSCIENCES DL-01's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
IGM BIOSCIENCES DL-01 Competitors by Market Cap
The table below lists competitors of IGM BIOSCIENCES DL-01 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Cheer Time Enterprise Co Ltd
TW:3229
|
$14.29 Million |
|
Sam Jung Pulp
KO:009770
|
$14.29 Million |
|
Zenith Minerals Ltd
AU:ZNC
|
$14.29 Million |
|
Rimfire Pacific Mining Ltd
AU:RIM
|
$14.30 Million |
|
Matahari Putra Prima Tbk
JK:MPPA
|
$14.28 Million |
|
PYRAMID TECHNOPLAST ORD (BSE)
NSE:PYRAMID
|
$14.27 Million |
|
Little Green Pharma Ltd
AU:LGP
|
$14.26 Million |
|
IP40
F:IP40
|
$14.26 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in IGM BIOSCIENCES DL-01's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares IGM BIOSCIENCES DL-01's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently IGM BIOSCIENCES DL-01 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares IGM BIOSCIENCES DL-01's net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $1,291,084,078
- Average return on equity (ROE) among peers: -24.49%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| IGM BIOSCIENCES DL-01 (1K0) | €- | N/A | N/A | $14.29 Million |
| 09R (09R) | $-3.01 Million | 0.00% | 0.00x | $11.12 Million |
| IDORSIA AG (19T) | $-968.72 Million | 0.00% | 0.00x | $532.51 Million |
| 1S90 (1S90) | $-44.86 Million | 0.00% | 0.00x | $51.72 Million |
| Strategic Partners A/S (1TB0) | $14.24 Million | -182.90% | 0.36x | $1.31 Million |
| 25K0 (25K0) | $-16.66 Million | 0.00% | 0.00x | $102.39 Million |
| 2BO (2BO) | $-37.78 Million | 0.00% | 0.00x | $6.23 Million |
| Intervacc AB (publ) (2E9) | $237.93 Million | -43.23% | 0.09x | $3.46 Million |
| 2F5 (2F5) | $-4.57 Million | 0.00% | 0.00x | $2.14 Million |
| 2H0 (2H0) | $14.92 Million | -17.30% | 0.56x | $9.25 Million |
| GNI Group Ltd (3G6) | $13.72 Billion | -1.46% | 0.26x | $772.60 Million |